Inhaled treprostinil for interstitial lung disease-associated pulmonary hypertension: a silver lining on a very dark cloud

被引：3
|
作者：
Cottin, Vincent [1 ]
Valenzuela, Claudia [2 ]
Humbert, Marc [3 ]
机构：
[1] Claude Bernard Univ Lyon 1, Louis Pradel Hosp, Natl Reference Ctr Rare Pulm Dis, Hosp Civils Lyon,ERN LUNG,UMR 754, Lyon, France
[2] Univ Autonoma Madrid, Hosp Univ Princesa, Madrid, Spain
[3] Univ Paris Saclay, Bicetre Hosp, Natl Reference Ctr Pulm Hypertens,AP HP, ERN LUNG,Inserm 999, Paris, Le Kremlin Bice, France
来源：
EUROPEAN RESPIRATORY JOURNAL | 2023年 / 61卷 / 06期
关键词：
CONTROLLED-TRIAL; FIBROSIS; SILDENAFIL; EFFICACY; CAPACITY; BOSENTAN; OUTCOMES;
D O I：
10.1183/13993003.00944-2023
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页数：5
相关论文
共 50 条
  • [41] Pulmonary hypertension in interstitial lung disease
    Nathan, S. D.
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2008, 62 : 21 - 28
  • [42] Subcutaneous Treprostinil for Pulmonary Hypertension in Chronic Lung Disease of Infancy
    Ferdman, Dina J.
    Rosenzweig, Erika B.
    Zuckerman, Warren A.
    Krishnan, Usha
    [J]. PEDIATRICS, 2014, 134 (01) : E274 - E278
  • [43] Connective tissue disease-associated interstitial lung disease
    Storrer, Karin Mueller
    Mueller, Carolina de Souza
    de Albuquerque Pessoa, Maxwell Cassio
    de Castro Pereira, Carlos Alberto
    [J]. JORNAL BRASILEIRO DE PNEUMOLOGIA, 2024, 50 (01)
  • [44] Collagen vascular disease-associated interstitial lung disease
    Christine L Vigeland
    Maureen R Horton
    [J]. World Journal of Respirology, 2015, (02) : 93 - 101
  • [45] Connective Tissue Disease-Associated Interstitial Lung Disease
    Fischer, Aryeh
    Brasington, Richard D.
    [J]. CURRENT RESPIRATORY MEDICINE REVIEWS, 2015, 11 (02) : 72 - 72
  • [46] Connective tissue disease-associated interstitial lung disease
    Oliveira, R. P.
    Ribeiro, R.
    Melo, L.
    Grima, B.
    Oliveira, S.
    Alves, J. D.
    [J]. PULMONOLOGY, 2022, 28 (02): : 113 - 118
  • [47] Outcomes of lung disease-associated pulmonary hypertension and impact of elevated pulmonary vascular resistance
    Awerbach, Jordan D.
    Stackhouse, Kathryn A.
    Lee, Joanne
    Dahhan, Talal
    Parikh, Kishan S.
    Krasuski, Richard A.
    [J]. RESPIRATORY MEDICINE, 2019, 150 : 126 - 130
  • [48] Practical considerations in the management of inhaled prostacyclin therapy for pulmonary hypertension associated with interstitial lung disease (WHO group 3)
    Lee, Charlie
    Hamlyn, Joan
    Porcelli, Julie
    Schmit, Ann
    [J]. RESPIRATORY MEDICINE, 2022, 196
  • [49] The use of sildenafil to treat pulmonary hypertension associated with interstitial lung disease
    Corte, Tamera J.
    Gatzoulis, Michael A.
    Parfitt, Lisa
    Harries, Carl
    Wells, Athol U.
    Wort, S. John
    [J]. RESPIROLOGY, 2010, 15 (08) : 1226 - 1232
  • [50] Interstitial lung disease and pulmonary hypertension associated with epidermolysis bullosa in an infant
    Doeker, B
    Hussein, A
    Trowitzsch, E
    [J]. KLINISCHE PADIATRIE, 1998, 210 (05): : 340 - 344
12345